Accordingly, the aim of this study was to compare perioperative glycemic control strategies in patients with type 2 diabetes mellitus on the first day after coronary artery bypass grafting (continuous intravenous insulin infusion therapy and standard therapy with bolus insulin administration) in terms of their impact on glycemic indices and hospital complications. The gene discussed is INS; the disease is type 2 diabetes mellitus.